A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.
10-15% of invasive epithelial ovarian cancer is attributable to hereditary breast and ovarian cancer. The identification of BRCA1/BRCA2 mutations in women with ovarian cancer allows for accurate predictive genetic testing of their at-risk relatives, who can then avail themselves of early detection and risk reduction strategies. In the case of women with recurrent progressive ovarian cancer, the window of opportunity for genetic testing can be particularly limited. Here we describe our perspective on providing genetic counseling during these patients' end of life care, incorporating two illustrative examples from our clinical practice. While these situations pose unique challenges, they also present a significant opportunity to benefit the patient and her family. Further attention and research should be directed towards provision of genetic counseling and testing during end of life care.
U.T.M.D. Anderson Cancer Center, Department of Gynecologic Oncology, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA. msdaniel@mdanderson.org
Molly S
MS
Daniels
Jennifer K
JK
Burzawa
Amanda C
AC
Brandt
Kathleen M
KM
Schmeler
Karen H
KH
Lu
D000328:Adult; D005260:Female; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000628:therapy; D013727:Terminal Care
Am J Hum Genet. 1995 Jan;56(1):265-71
7825587
Cancer Res. 2006 Aug 1;66(15):7810-7
16885385
JAMA. 2010 Sep 1;304(9):967-75
20810374
Gynecol Oncol. 2005 Nov;99(2):255-6
16198397
N Engl J Med. 2005 May 5;352(18):1851-60
15872200
Gynecol Oncol. 2008 Oct;111(1):132-6
18684498
Eur J Cancer. 2004 Feb;40(3):422-8
14746861
J Clin Oncol. 2010 Feb 1;28(4):675-82
19841329
J Palliat Med. 2008 Apr;11(3):451-8
18363488
Am J Hum Genet. 2001 Mar;68(3):700-10
11179017
Am J Hum Genet. 1998 Mar;62(3):676-89
9497246
J Clin Oncol. 2007 Apr 10;25(11):1329-33
17416853
J Clin Oncol. 2008 Mar 10;26(8):1331-7
18268356
Lancet. 2010 Jul 24;376(9737):245-51
20609468
Int J Palliat Nurs. 2006 Feb;12(2):70-4
16603995
J Genet Couns. 2010 Oct;19(5):497-525
20680422
Genet Med. 2009 Sep;11(9):624-8
19606053
Am J Hum Genet. 2003 May;72(5):1117-30
12677558
Cancer Res. 2007 Oct 1;67(19):9603
17909073
Obstet Gynecol. 2010 May;115(5):945-952
20410767
Cancer Res. 2006 Aug 15;66(16):8297-308
16912212
Cancer. 2005 Dec 15;104(12):2807-16
16284991